Merck CEO Belén Garijo Expresses Confidence in Resilient Growth Model for 2024

Transitional year 2023 managed well so far thanks to resilient business model Medium-term growth targets confirmed Merck expects continued growth also ...

October 25, 2023 | Wednesday | Company results
Novartis Reports Stellar Quarter with Double-Digit Sales Growth, CEO Vas Narasimhan Confident in Strong Mid-Term Outlook

Transformation into a “pure-play” innovative medicines business is complete, with the spin-off of Sandoz; commentary below is on continuing o...

October 24, 2023 | Tuesday | Company results
Government of Serbia and Ginkgo Bioworks Announce Bioeconomy Collaboration in BIO4 Campus

Under the planned partnership, Ginkgo and the Serbian Ministry of Science, Technological Development and Innovation will work to establish a Startup Accele...

October 23, 2023 | Monday | News
Sartorius CEO Joachim Kreuzburg Foresees Gradual Recovery in 2023, Eyes Strong Growth in 2024 and Beyond

Sales revenue in constant currencies down 16.4 percent, excluding Covid-19-related business down slightly above 10 percent; underlying EBITDA marg...

October 20, 2023 | Friday | Company results
Novo Nordisk raises sales and operating profit outlook for 2023

In the first nine months of 2023, Novo Nordisk’s sales increased by 33% and operating profit increased by 37% both at CER. Profit and loss (CE...

October 16, 2023 | Monday | News
Astrazeneca Foundation Awards 12 Nonprofit Organizations More Than $2M to Advance Health Equity

AstraZeneca Foundation celebrates its 30th anniversary, the organization has awarded 12 nonprofit organizations $2,170,318 in grants across eight US states...

October 11, 2023 | Wednesday | News
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million

“Our ongoing partnership with Bayer leverages the full suite of our Twist Biopharma Solutions offering of antibody discovery services to identify the...

October 06, 2023 | Friday | News
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools

Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of mu...

October 05, 2023 | Thursday | News
MediciNova Receives Gene Therapy Milestone Payment

The milestone payment of $1 million is the result of the successful achievement of a clinical development milestone for a gene therapy product based o...

October 05, 2023 | Thursday | News
Debiopharm Innovation Fund Launches Seed Funding for Cancer Care Digital Transformation

--Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management,  announc...

September 29, 2023 | Friday | News
National Institute of Health to Fund Preclinical Development of Trethera Lead Drug, TRE-515, for Treatment of Crohn’s Disease

Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of c...

September 26, 2023 | Tuesday | News
Qihan Biotech Completes Pre-Series B Financing for Stem Cell-Derived Cell Therapy in China

Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to c...

September 25, 2023 | Monday | News
BrainScope Receives Investment from the Alzheimer’s Drug Discovery Foundation for Alzheimer's Prediction Biomarker

-Brain diagnostics innovator BrainScope announced  a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s ...

September 20, 2023 | Wednesday | News
Catalent Announces Governance Enhancements and New Initiatives to Drive Value

Adding Four New Independent Directors Appoints John Greisch as Executive Chair Establishes New Strategic and Operational Review Committee of the Board ...

August 30, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close